What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Immune system
His primary areas of study are Immunology, Primary biliary cirrhosis, Molecular biology, T cell and Epitope.
His Immunology study frequently draws connections to other fields, such as Cytotoxic T cell.
The various areas that Shinji Shimoda examines in his Primary biliary cirrhosis study include Biliary tract, Antigen, Pathology, Chemokine and Peripheral blood mononuclear cell.
His studies deal with areas such as Autoantibody and Cell division as well as Peripheral blood mononuclear cell.
His Molecular biology research is multidisciplinary, relying on both Progenitor cell, In situ hybridization and Cord blood.
The Epitope study combines topics in areas such as Molecular mimicry and Biochemistry, Peptide.
His most cited work include:
- HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. (265 citations)
- Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis (242 citations)
- Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. (204 citations)
What are the main themes of his work throughout his whole career to date?
Shinji Shimoda mainly focuses on Internal medicine, Immunology, Gastroenterology, Primary biliary cirrhosis and Ribavirin.
Shinji Shimoda combines subjects such as Chronic hepatitis, Telaprevir and Hepatitis C virus with his study of Internal medicine.
His Immunology study frequently draws connections to adjacent fields such as Cytotoxic T cell.
His research investigates the link between Gastroenterology and topics such as Hepatocellular carcinoma that cross with problems in Incidence and Hazard ratio.
His research in Primary biliary cirrhosis intersects with topics in Biliary tract, Pathology, Peripheral blood mononuclear cell and Epitope, Antibody.
The study incorporates disciplines such as Molecular biology and Peptide in addition to T cell.
He most often published in these fields:
- Internal medicine (45.74%)
- Immunology (39.01%)
- Gastroenterology (34.08%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (45.74%)
- Gastroenterology (34.08%)
- Cirrhosis (9.42%)
In recent papers he was focusing on the following fields of study:
Shinji Shimoda focuses on Internal medicine, Gastroenterology, Cirrhosis, Sofosbuvir and Immunology.
The Internal medicine study which covers Oncology that intersects with Chemotherapy.
The Gastroenterology study combines topics in areas such as Genotype and Hepatitis C virus.
Shinji Shimoda studied Cirrhosis and Pathology that intersect with Molecular biology.
His Clinical significance research extends to the thematically linked field of Immunology.
His work often combines Primary biliary cirrhosis and In patient studies.
Between 2015 and 2021, his most popular works were:
- Current epidemiology, genetic evolution and clinical impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae (67 citations)
- Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment. (51 citations)
- Hepatic stellate cells secreting WFA+-M2BP: Its role in biological interactions with Kupffer cells (43 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
Internal medicine, Cirrhosis, Gastroenterology, Immunology and Adverse effect are his primary areas of study.
His study in the fields of Odds ratio under the domain of Internal medicine overlaps with other disciplines such as Coagulase.
Shinji Shimoda has researched Cirrhosis in several fields, including Cholestasis, Ursodeoxycholic acid, Secretion and Disease, Pathology.
He interconnects Bile duct, Hepatology and Primary biliary cirrhosis in the investigation of issues within Cholestasis.
The concepts of his Gastroenterology study are interwoven with issues in Cohort study, Cohort and Hepatitis C virus.
Shinji Shimoda regularly links together related areas like Hematopoietic stem cell transplantation in his Immunology studies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
